These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72. Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960 [TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice. O'Hara JM; Brey RN; Mantis NJ Clin Vaccine Immunol; 2013 Jun; 20(6):789-94. PubMed ID: 23515013 [TBL] [Abstract][Full Text] [Related]
31. Construction and physiochemical characterisation of a multi-composite, potential oral vaccine delivery system (VDS). Pettit MW; Dyer PD; Mitchell JC; Griffiths PC; Alexander B; Cattoz B; Heenan RK; King SM; Schweins R; Pullen F; Wicks SR; Richardson SC Int J Pharm; 2014 Jul; 468(1-2):264-71. PubMed ID: 24680960 [TBL] [Abstract][Full Text] [Related]
33. Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccine. Hu L; Joshi SB; Liyanage MR; Pansalawatta M; Alderson MR; Tate A; Robertson G; Maisonneuve J; Volkin DB; Middaugh CR J Pharm Sci; 2013 Feb; 102(2):387-400. PubMed ID: 23161162 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant. Levesque PM; de Alwis U Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824 [TBL] [Abstract][Full Text] [Related]
35. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants. Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994 [TBL] [Abstract][Full Text] [Related]
36. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008 [TBL] [Abstract][Full Text] [Related]
37. Factors affecting alum-protein interactions. Huang M; Wang W Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202 [TBL] [Abstract][Full Text] [Related]
38. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation. Deng J; Cai W; Jin F Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309 [TBL] [Abstract][Full Text] [Related]
39. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody. Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195 [TBL] [Abstract][Full Text] [Related]
40. A novel recombinant vaccine which protects mice against ricin intoxication. Smallshaw JE; Firan A; Fulmer JR; Ruback SL; Ghetie V; Vitetta ES Vaccine; 2002 Sep; 20(27-28):3422-7. PubMed ID: 12213413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]